We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Hims & Hers Health Inc (HIMS) USD0.0001 A

Sell:$25.33 Buy:$25.34 Change: $1.18 (4.89%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Sell:$25.33
Buy:$25.34
Change: $1.18 (4.89%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Sell:$25.33
Buy:$25.34
Change: $1.18 (4.89%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. Its platform includes access to a provider network, a clinically focused electronic medical records system, digital prescriptions and cloud-enabled pharmacy fulfillment. Its digital platform enables access to treatments for a range of conditions, including sexual health, men’s and women’s dermatology, mental health, and weight loss. It connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Through the Hims & Hers mobile applications, consumers can access a range of educational programs, wellness content, community support, and other services. It offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. It offers pharmacy operation capabilities through its MedisourceRx, a 503B outsourcing facility in California.

Contact details

Address:
2269 Chestnut St, #523
SAN FRANCISCO
94123
United States
Telephone:
+1 (415) 8510195
Website:
https://www.forhims.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HIMS
ISIN:
US4330001060
Market cap:
$4.76 billion
Shares in issue:
218.48 million
Sector:
Health Care Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Andrew Dudum
    Chairman of the Board, Chief Executive Officer
  • Oluyemi Okupe
    Chief Financial Officer
  • Melissa Baird
    Chief Operating Officer
  • Mike Chi
    Chief Marketing Officer
  • Jessica Shepherd
    Chief Medical Officer
  • Soleil Boughton
    Chief Legal Officer, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.